Welcome to the forefront of innovation in clinical trials! Our dedicated space for TRI's Risk-Based Quality Management insights is where cutting-edge practices meet practical guidance. Dive into our expertly curated blog, your go-to resource for the latest in RBQM methodologies, training opportunities, and thought leadership.
Welcome to the forefront of innovation in clinical trials! Our dedicated space for TRI's Risk-Based Quality Management insights is where cutting-edge practices meet practical guidance. Dive into our expertly curated blog, your go-to resource for the latest in RBQM methodologies, training opportunities, and thought leadership.
TRI launches major overhaul of OPRA-CM to unlock the full potential of Centralized Monitoring in clinical trials TRI, a leading innovator in Risk-Based Quality Management (RBQM) technology, today announced the launch of the latest version of OPRA-CM, a reimagined centralized monitoring platform built to help clinical teams achieve the efficiency and focus RBQM has long […]
Happy Clinical Trials Day! 🎉 In this edition of the Quality Issue, we discuss the origin of this day, a new research study by The Tufts CSDD, and of course, some dates for your diary at the end of May and beginning of June. National Clinical Trials Day is celebrated on May 20th each year […]
I am writing this blog from my mobile office (the train home) after an exhausting but incredibly informative two days of executive briefing meetings and one on ones in London. What a way to immerse myself in a pool of talent and thought leadership! So, what did I learn? As an industry we are still […]
📅 What’s On: RBQM Events Worth Attending In this edition of the Quality Issue, we’re highlighting some key events across Europe and North America that are well worth attending if you’re interested in Risk-Based Quality Management (RBQM) and involved in clinical trials. Whether you’re looking to stay up to date on regulatory trends, connect with […]
Join Us at the SCDM 2025 EMEA Conference We’re excited to announce that TRI – The RBQM Experts will be exhibiting at the SCDM 2025 EMEA Conference in Brussels, Belgium, from 9-11 April 2025. This premier event is a must-attend for clinical data management professionals looking to stay ahead in the industry. The conference will […]
Reflecting on Two Great Conferences – Let’s Talk! In this edition of the Quality Issue, we’re taking a moment to look back on two fantastic conferences we’ve recently attended. Too often, we move from one event to the next without stopping to reflect—so we’re changing that! Take five, grab a coffee (or your beverage of […]
Happy New Year, and welcome to our first Quality Issue of 2025! It this edition, we spotlight some of the most important developments in clinical research and Risk-Based Quality Management (RBQM). 2025 is going to be an interesting year for RBQM. Our prediction is that there’s going to be an increased focus on Central Monitoring […]
The complexities of oncology drug development have long posed significant challenges, particularly in determining the optimal dose that balances therapeutic efficacy with patient safety. The FDA’s recent guidance on dose optimization1 represents a significant milestone in addressing these concerns by refining outdated dose-finding methodologies. This article explores how dose optimization can enhance both patient safety […]
Partnership will drive quality and efficiency in clinical trials through enhanced risk-based quality management integration. [Cambridge, UK – 17.10.2024] – TRI, a leading Risk-Based Quality Management (RBQM) software provider for clinical trials, today announced it has become an official Veeva Product Partner. TRI’s OPRA RBQM platform will now be integrated with Veeva Vault EDC, providing […]
The Society for Clinical Data Management (SCDM) annual conference has always been a cornerstone for clinical data professionals, but this year’s event, held in Boston from September 30th to October 2nd, felt like a turning point for the industry. Clinical data management is on the cusp of a technological revolution, and at the heart of […]
